Rai14 is a novel interactor of Invariant chain that regulates macropinocytosis.
Rai14
antigen presenting cell (APC)
cell migration
cytoskeleton
invariant chain
macropinocytosis
myosin II
Journal
Frontiers in immunology
ISSN: 1664-3224
Titre abrégé: Front Immunol
Pays: Switzerland
ID NLM: 101560960
Informations de publication
Date de publication:
2023
2023
Historique:
received:
08
03
2023
accepted:
30
06
2023
medline:
8
8
2023
pubmed:
7
8
2023
entrez:
7
8
2023
Statut:
epublish
Résumé
Invariant chain (Ii, CD74) is a type II transmembrane glycoprotein that acts as a chaperone and facilitates the folding and transport of MHC II chains. By assisting the assembly and subcellular targeting of MHC II complexes, Ii has a wide impact on the functions of antigen-presenting cells such as antigen processing, endocytic maturation, signal transduction, cell migration, and macropinocytosis. Ii is a multifunctional molecule that can alter endocytic traffic and has several interacting molecules. To understand more about Ii's function and to identify further Ii interactors, a yeast two-hybrid screening was performed. Retinoic Acid-Induced 14 (Rai14) was detected as a putative interaction partner, and the interaction was confirmed by co-immunoprecipitation. Rai14 is a poorly characterized protein, which is believed to have a role in actin cytoskeleton and membrane remodeling. In line with this, we found that Rai14 localizes to membrane ruffles, where it forms macropinosomes. Depletion of Rai14 in antigen-presenting cells delays MHC II internalization, affecting macropinocytic activity. Intriguingly, we demonstrated that, similar to Ii, Rai14 is a positive regulator of macropinocytosis and a negative regulator of cell migration, two antagonistic processes in antigen-presenting cells. This antagonism is known to depend on the interaction between myosin II and Ii. Here, we show that Rai14 also binds to myosin II, suggesting that Ii, myosin II, and Rai14 work together to coordinate macropinocytosis and cell motility.
Identifiants
pubmed: 37545539
doi: 10.3389/fimmu.2023.1182180
pmc: PMC10401043
doi:
Substances chimiques
invariant chain
0
Tretinoin
5688UTC01R
Histocompatibility Antigens Class II
0
Cytoskeletal Proteins
0
Myosin Type II
EC 3.6.1.-
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
1182180Informations de copyright
Copyright © 2023 Lobos Patorniti, Zulkefli, McAdam, Vargas, Bakke and Progida.
Déclaration de conflit d'intérêts
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Références
Genes Cells. 2000 Dec;5(12):1001-8
pubmed: 11168586
J Cell Sci. 2020 Oct 9;133(19):
pubmed: 32907852
Nat Rev Immunol. 2012 Jul 13;12(8):557-69
pubmed: 22790179
Cell. 2011 Apr 15;145(2):268-83
pubmed: 21458045
Nature. 2008 May 1;453(7191):51-5
pubmed: 18451854
iScience. 2019 Jul 26;17:101-118
pubmed: 31255983
Biochemistry. 2006 Apr 25;45(16):5228-34
pubmed: 16618111
Front Cell Dev Biol. 2023 Jan 25;11:1050323
pubmed: 36760361
Spermatogenesis. 2013 Apr 1;3(2):e24824
pubmed: 23885305
Nat Cell Biol. 2019 Oct;21(10):1191-1205
pubmed: 31548610
Exp Mol Pathol. 2008 Aug;85(1):40-4
pubmed: 18547561
J Cell Sci. 2021 Sep 15;134(18):
pubmed: 34494097
J Immunol Methods. 2016 May;432:30-4
pubmed: 26684937
Membranes (Basel). 2020 Aug 03;10(8):
pubmed: 32756454
J Biol Chem. 2001 Jan 26;276(4):2831-40
pubmed: 11042181
Scand J Immunol. 2009 Sep;70(3):184-93
pubmed: 19703008
Curr Opin Cell Biol. 2021 Feb;68:10-19
pubmed: 32927373
Blood. 2012 Jan 5;119(1):238-50
pubmed: 21908426
Science. 2008 Dec 12;322(5908):1705-10
pubmed: 19074353
Mol Biol Cell. 2008 Mar;19(3):765-75
pubmed: 18094044
Proc Natl Acad Sci U S A. 1993 Sep 15;90(18):8581-5
pubmed: 8397411
PLoS One. 2013;8(4):e60656
pubmed: 23565266
Proc Natl Acad Sci U S A. 2005 May 31;102(22):7910-5
pubmed: 15911768
J Cell Biol. 2011 Jun 27;193(7):1289-303
pubmed: 21708980
Nat Rev Immunol. 2011 Nov 11;11(12):823-36
pubmed: 22076556
Biol Open. 2012 Aug 15;1(8):754-60
pubmed: 23213469
Mol Biol Cell. 2000 Oct;11(10):3341-52
pubmed: 11029040
Curr Opin Immunol. 2019 Jun;58:1-8
pubmed: 30738283
Neurosci Lett. 2006 Sep 1;404(3):294-8
pubmed: 16806700
Nat Protoc. 2014 Jan;9(1):182-92
pubmed: 24385148
Immunol Cell Biol. 2011 Jul;89(5):619-29
pubmed: 21116285
J Cell Sci. 2014 Nov 15;127(Pt 22):4927-39
pubmed: 25217632
Eur J Immunol. 2014 Mar;44(3):774-84
pubmed: 24293164
Nat Commun. 2015 Jun 25;6:7526
pubmed: 26109323
Curr Biol. 1998 Aug 27;8(17):967-70
pubmed: 9742399
J Cell Sci. 2021 Apr 1;134(7):
pubmed: 33722976
Immunol Rev. 2013 Nov;256(1):240-54
pubmed: 24117825
Proc Natl Acad Sci U S A. 1992 Mar 15;89(6):2282-6
pubmed: 1549594
EMBO J. 1986 Dec 20;5(13):3483-8
pubmed: 3104027
Biochim Biophys Acta. 2016 Jun;1863(6 Pt A):1269-81
pubmed: 27033518
Methods Mol Biol. 2011;769:415-34
pubmed: 21748692